Myomo (MYO) Research & Development (2016 - 2025)

Myomo (MYO) has reported Research & Development for 10 consecutive years, with $5.3 million the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, Research & Development rose 54.48% year-over-year to $5.3 million; the trailing twelve-month figure through Sep 2025 stood at $18.6 million (up 70.57% YoY), and the FY2024 full-year result was $12.2 million, up 35.32% from the prior year.
• Research & Development held at $5.3 million in Q3 2025 per MYO's latest filing, from $5.2 million in the prior quarter.
• Across five years, Research & Development topped out at $5.3 million in Q3 2025 and bottomed at $499674.0 in Q4 2022.
• Historically, Research & Development has averaged $2.2 million across 5 years, with a median of $2.3 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Research & Development tumbled 36.56% in 2022, then surged 370.93% in 2023.
• Over 5 years, Research & Development stood at $787628.0 in 2021, then slumped by 36.56% to $499674.0 in 2022, then soared by 370.93% to $2.4 million in 2023, then surged by 57.1% to $3.7 million in 2024, then jumped by 42.13% to $5.3 million in 2025.
• According to Business Quant data, Research & Development over the past three periods registered $5.3 million, $5.2 million, and $4.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.